The HLA-B*2709 subtype in a woman with early ankylosing spondylitis.
Olivieri
Ignazio
I
San Carlo Hospital, Potenza, Italy.
D'Angelo
Salvatore
S
Scarano
Enrico
E
Santospirito
Vincenzo
V
Padula
Angela
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D005260:Female; D020022:Genetic Predisposition to Disease; D015235:HLA-B Antigens / Q000235:genetics*; D015796:HLA-B27 Antigen; D006239:Haplotypes; D006650:Histocompatibility Testing; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D010147:Pain Measurement; D012446:Sacroiliac Joint / Q000473:pathology; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015235:HLA-B Antigens; C464937:HLA-B*27:09 antigen; D015796:HLA-B27 Antigen; D000069285:Infliximab